Descriptive Pharmacoepidemiological Study of Patients Treated With Iressa.

Trial Profile

Descriptive Pharmacoepidemiological Study of Patients Treated With Iressa.

Completed
Phase of Trial: Phase IV

Latest Information Update: 11 Oct 2016

At a glance

  • Drugs Gefitinib (Primary)
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Acronyms EPIDAURE
  • Sponsors AstraZeneca
  • Most Recent Events

    • 11 Oct 2016 Results of EGFR exon 19 Del and L858R mutation subtypes, presented at the 41st European Society for Medical Oncology Congress.
    • 28 Jun 2016 Status changed from active, no longer recruiting to completed.
    • 21 Aug 2013 Planned End Date changed from 1 Jan 2015 to 1 Mar 2015 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top